These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8726544)

  • 1. Involvement of the endogenous opioid system in the drinking behavior of schizophrenic patients displaying self-induced water intoxication: a double-blind controlled study with naloxone.
    Nishikawa T; Tsuda A; Tanaka M; Nishikawa M; Koga I; Uchida Y
    Clin Neuropharmacol; 1996 Jun; 19(3):252-8. PubMed ID: 8726544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone attenuates drinking behavior in psychiatric patients displaying self-induced water intoxication.
    Nishikawa T; Tsuda A; Tanaka M; Nishikawa M; Koga I; Uchida Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):149-53. PubMed ID: 8115669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone attenuates drinking behavior in a schizophrenic patient displaying self-induced water intoxication.
    Nishikawa T; Tsuda A; Tanaka M; Nishikawa M; Koga I; Uchida Y
    Clin Neuropharmacol; 1992 Aug; 15(4):310-4. PubMed ID: 1516076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the alpha2-adrenergic system in polydipsia in schizophrenic patients: a pilot study.
    Hayashi T; Nishikawa T; Koga I; Uchida Y; Horiguchi J; Yamawaki S
    Psychopharmacology (Berl); 1997 Apr; 130(4):382-6. PubMed ID: 9160855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychogenic polydipsia and water intoxication--concepts that have failed.
    Vieweg WV; David JJ; Rowe WT; Peach MJ; Veldhuis JD; Kaiser DL; Spradlin WW
    Biol Psychiatry; 1985 Dec; 20(12):1308-20. PubMed ID: 4063421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.
    Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS
    Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
    Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
    Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
    Vieweg V; Pandurangi A; Levenson J; Silverman J
    Int J Psychiatry Med; 1994; 24(4):275-303. PubMed ID: 7737786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous opioid effects on motoneuron pool excitability: potential analgesic effect of acute exercise.
    Bulbulian R
    J Manipulative Physiol Ther; 2002 May; 25(4):209-15. PubMed ID: 12021739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
    Fudala PJ; Yu E; Macfadden W; Boardman C; Chiang CN
    Drug Alcohol Depend; 1998 Mar; 50(1):1-8. PubMed ID: 9589267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demeclocycline in the prophylaxis of self-induced water intoxication.
    Nixon RA; Rothman JS; Chin W
    Am J Psychiatry; 1982 Jun; 139(6):828-30. PubMed ID: 6805340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological manifestations of hyponatremia in chronic schizophrenic patients with the syndrome of psychosis, intermittent hyponatremia and polydipsia (PIP).
    Shutty MS; Briscoe L; Sautter S; Leadbetter RA
    Schizophr Res; 1993 Aug; 10(2):125-30. PubMed ID: 8398944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low-dose Naloxone as an Adjuvant to Patient Controlled Analgesia (PCA) With Morphine for Postoperative Pain Relief Following Lumber Discectomy: A Double-blind, Randomized, Placebo-controlled Trial.
    Firouzian A; Gholipour Baradari A; Alipour A; Emami Zeydi A; Zamani Kiasari A; Emadi SA; Kheradmand B; Hadadi K
    J Neurosurg Anesthesiol; 2018 Jan; 30(1):26-31. PubMed ID: 27673505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive quetiapine treatment of the polydipsia, intermittent hyponatremia, and psychosis syndrome: a case report.
    Montgomery JH; Tekell JL
    J Clin Psychiatry; 2003 Mar; 64(3):339-41. PubMed ID: 12716283
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of naltrexone on mannerisms and water imbalance in polydipsic schizophrenics: a pilot study.
    Becker JA; Goldman MB; Alam MY; Luchins DJ
    Schizophr Res; 1995 Nov; 17(3):279-82. PubMed ID: 8664207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.
    Rosow CE; Gomery P; Chen TY; Stefanovich P; Stambler N; Israel R
    Clin Pharmacol Ther; 2007 Jul; 82(1):48-53. PubMed ID: 17392726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine treatment in polydipsia and intermittent hyponatremia.
    Spears NM; Leadbetter RA; Shutty MS
    J Clin Psychiatry; 1996 Mar; 57(3):123-8. PubMed ID: 8617697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous opioid tone in patients with rheumatoid arthritis.
    Kassimos D; Choy EH; Grossman AB; Chikanza IC; Panayi GS
    Br J Rheumatol; 1996 May; 35(5):436-40. PubMed ID: 8646433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of naloxone in chronic schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Morphine and Naloxone on Pain Modulation in Rheumatoid Arthritis, Chronic Fatigue Syndrome/Fibromyalgia, and Controls: A Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study.
    Hermans L; Nijs J; Calders P; De Clerck L; Moorkens G; Hans G; Grosemans S; Roman De Mettelinge T; Tuynman J; Meeus M
    Pain Pract; 2018 Apr; 18(4):418-430. PubMed ID: 28722815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.